MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.
暂无分享,去创建一个
Gideon Rechavi | Victor G Prieto | Iris Barshack | Gal Markel | Ninette Amariglio | Elad Jacoby | Lyn M Duncan | I. Barshack | J. Schachter | E. Eyal | N. Amariglio | G. Rechavi | M. Bar‐eli | D. Bennett | J. Jacob-Hirsch | V. Prieto | G. Markel | R. Ortenberg | M. Besser | Menashe Bar-Eli | Eran Eyal | Jasmine Jacob-Hirsch | E. Jacoby | L. Duncan | Eyal Greenberg | Yael Nemlich | Rona Ortenberg | Jacob Schachter | Ludmila Rivkin | Michal J Besser | Dorothy C Bennett | Nitin Chakravarti | David M Kallenberg | Eitan Galun | Ludmila Rivkin | N. Chakravarti | E. Galun | Eyal Greenberg | David M. Kallenberg | Yael Nemlich
[1] V. Kim. MicroRNA biogenesis: coordinated cropping and dicing , 2005, Nature Reviews Molecular Cell Biology.
[2] M. O’Connell,et al. The many roles of an RNA editor , 2001, Nature Reviews Genetics.
[3] K. Nishikura,et al. Mutagenic Analysis of Double-stranded RNA Adenosine Deaminase, a Candidate Enzyme for RNA Editing of Glutamate-gated Ion Channel Transcripts (*) , 1995, The Journal of Biological Chemistry.
[4] N. Rajewsky,et al. Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.
[5] Masato Nagino,et al. let-7 regulates Dicer expression and constitutes a negative feedback loop. , 2008, Carcinogenesis.
[6] C. Samuel,et al. Adenosine deaminase ADAR1 increases gene expression at the translational level by decreasing protein kinase PKR-dependent eIF-2alpha phosphorylation. , 2009, Journal of molecular biology.
[7] M. Jantsch,et al. RNA-Regulated Interaction of Transportin-1 and Exportin-5 with the Double-Stranded RNA-Binding Domain Regulates Nucleocytoplasmic Shuttling of ADAR1 , 2009, Molecular and Cellular Biology.
[8] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[9] K. Nishikura,et al. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. , 2005, Progress in nucleic acid research and molecular biology.
[10] Noam Shomron,et al. Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs , 2011, PloS one.
[11] Yukio Kawahara,et al. RNA editing of the microRNA‐151 precursor blocks cleavage by the Dicer–TRBP complex , 2007, EMBO reports.
[12] E. Hatano,et al. The NF90-NF45 Complex Functions as a Negative Regulator in the MicroRNA Processing Pathway , 2009, Molecular and Cellular Biology.
[13] Yong Liu,et al. Adenosine deaminases acting on RNA, RNA editing, and interferon action. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[14] Boris Zinshteyn,et al. Adenosine‐to‐inosine RNA editing , 2009, Wiley interdisciplinary reviews. Systems biology and medicine.
[15] A. Hamilton,et al. Improved northern blot method for enhanced detection of small RNA , 2008, Nature Protocols.
[16] Bjorn-Erik Wulff,et al. Modulation of microRNA expression and function by ADARs. , 2012, Current topics in microbiology and immunology.
[17] K. Nishikura,et al. Editor meets silencer: crosstalk between RNA editing and RNA interference , 2006, Nature Reviews Molecular Cell Biology.
[18] N. Amariglio,et al. A-to-I RNA editing: a new regulatory mechanism of global gene expression. , 2007, Blood cells, molecules & diseases.
[19] Martina Paulsen,et al. Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene , 2003, Nature Genetics.
[20] Molly Megraw,et al. Frequency and fate of microRNA editing in human brain , 2008, Nucleic acids research.
[21] Xiaoxing Luo,et al. p150 ADAR1 isoform involved in maintenance of HeLa cell proliferation , 2006, BMC Cancer.
[22] P. Kao,et al. ADAR1 Interacts with NF90 through Double-Stranded RNA and Regulates NF90-Mediated Gene Expression Independently of RNA Editing , 2005, Molecular and Cellular Biology.
[23] Shahar Alon,et al. Systematic identification of edited microRNAs in the human brain , 2012, Genome research.
[24] Erez Y. Levanon,et al. Evolutionarily conserved human targets of adenosine to inosine RNA editing , 2005, Nucleic acids research.
[25] M. O’Connell,et al. Down-regulation of RNA Editing in Pediatric Astrocytomas , 2008, Journal of Biological Chemistry.
[26] I. Gromova,et al. Human BLCAP transcript: new editing events in normal and cancerous tissues , 2009, International journal of cancer.
[27] J. Schachter,et al. Systemic dysregulation of CEACAM1 in melanoma patients , 2010, Cancer Immunology, Immunotherapy.
[28] B. Shalmon,et al. Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients , 2010, Clinical Cancer Research.
[29] P. Seeburg,et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases , 2006, Nature Structural &Molecular Biology.
[30] M. Mathews,et al. Proteins binding to duplexed RNA: one motif, multiple functions. , 2000, Trends in biochemical sciences.
[31] Michael R. Green,et al. Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7 , 2008, Cell.
[32] T. Cheng,et al. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing , 2009, Proceedings of the National Academy of Sciences.
[33] M. O’Connell,et al. Editing independent effects of ADARs on the miRNA/siRNA pathways , 2009, The EMBO journal.
[34] A. Ferguson-Smith,et al. Genomic imprinting at the mammalian Dlk1-Dio3 domain. , 2008, Trends in genetics : TIG.
[35] R. Malik,et al. RNA regulation and cancer development. , 2007, Cancer letters.
[36] A. Hatzigeorgiou,et al. Redirection of Silencing Targets by Adenosine-to-Inosine Editing of miRNAs , 2007, Science.
[37] Lin He,et al. mir-17-92, a cluster of miRNAs in the midst of the cancer network. , 2010, The international journal of biochemistry & cell biology.
[38] M. O’Connell,et al. Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes , 2004, Genome Biology.
[39] Angela Gallo,et al. A-to-I RNA editing: the "ADAR" side of human cancer. , 2012, Seminars in cell & developmental biology.
[40] S. Orkin,et al. Corrigendum: ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling , 2009, Nature Immunology.
[41] Gideon Rechavi,et al. Adenosine-to-inosine RNA editing meets cancer. , 2011, Carcinogenesis.
[42] Richard J Lamont,et al. Overexpression of dicer as a result of reduced let‐7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells , 2010, Genes, chromosomes & cancer.
[43] T. Mikkelsen,et al. Altered adenosine-to-inosine RNA editing in human cancer. , 2007, Genome research.
[44] C. Samuel,et al. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. , 2011, Virology.
[45] K. Nishikura. Functions and regulation of RNA editing by ADAR deaminases. , 2010, Annual review of biochemistry.
[46] J. Martinez-Climent,et al. Epigenetic regulation of miRNA genes in acute leukemia , 2012, Leukemia.
[47] F. Major,et al. The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data , 2008, Nature.
[48] M. Weiss,et al. Stress-induced Apoptosis Associated with Null Mutation of ADAR1 RNA Editing Deaminase Gene* , 2004, Journal of Biological Chemistry.
[49] A. Nagler,et al. A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD). , 2008, Leukemia research.
[50] Joshua J. Forman,et al. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence , 2008, Proceedings of the National Academy of Sciences.
[51] A. Rich,et al. The Zalpha domain from human ADAR1 binds to the Z-DNA conformer of many different sequences. , 1998, Nucleic acids research.
[52] M. Wolter,et al. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures , 2010, Oncogene.
[53] Albert Zlotnik,et al. Homeostatic chemokine receptors and organ-specific metastasis , 2011, Nature Reviews Immunology.
[54] Prachi Mishra,et al. DNA hypermethylation as a chemotherapy target. , 2011, Cellular signalling.
[55] S. Maas,et al. Characterization of ADAR1-mediated modulation of gene expression. , 2008, Biochemical and biophysical research communications.
[56] Z. Paroo,et al. Phosphorylation of the Human MicroRNA-Generating Complex Mediates MAPK/Erk Signaling , 2009, Cell.
[57] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[58] K. Nishikura,et al. A new function for the RNA-editing enzyme ADAR1 , 2009, Nature Immunology.
[59] Anna M. Krichevsky,et al. miR-21: a small multi-faceted RNA , 2008, Journal of cellular and molecular medicine.
[60] G. Zheng,et al. Abnormal expression of ADAR1 isoforms in Chinese pediatric acute leukemias. , 2011, Biochemical and biophysical research communications.
[61] Zipora Y. Fligelman,et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome , 2004, Nature Biotechnology.
[62] W. Filipowicz,et al. The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.